Bison Wealth, LLC Abb Vie Inc. Transaction History

Bison Wealth, LLC

$581 Million
Q2 2024

A detailed history of Bison Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bison Wealth, LLC holds 18,670 shares of ABBV stock, worth $3.61 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

18,670

Previous 18,670 -0.0%

Holding current value

$3.61 Million

Previous $3.4 Million 5.8%

% of portfolio

0.55%

Previous 0.59%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $570,237 - $649,732	3,568 Added 23.63%	18,670 $3.4 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $5,779 - $6,508	42 Added 0.28%	15,102 $2.34 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $9,618 - $11,134	-72 Reduced 0.48%	15,060 $2.24 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $415,021 - $516,466	3,132 Added 26.1%	15,132 $2.04 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $105,854 - $121,907	-732 Reduced 5.75%	12,000 $1.91 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $192,665 - $231,056	-1,393 Reduced 9.86%	12,732 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $51,134 - $58,647	381 Added 2.77%	14,125 $1.9 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $243,174 - $309,154	1,767 Added 14.75%	13,744 $2.11 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $390,264 - $484,208	2,957 Added 32.78%	11,977 $1.94 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $128,056 - $162,028	1,192 Added 15.23%	9,020 $1.22 Million
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $19,364 - $21,981	-182 Reduced 2.27%	7,828 $844,000
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $44,609 - $49,697	424 Added 5.59%	8,010 $902,000
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $225,878 - $248,664	2,208 Added 41.06%	7,586 $606,000
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $13,924 - $18,799	-173 Reduced 3.12%	5,378 $576,000
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $31,185 - $36,601	-363 Reduced 6.14%	5,551 $486,000
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $50,698 - $67,842	691 Added 13.23%	5,914 $581,000
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $13,932 - $21,122	-216 Reduced 3.97%	5,223 $398,000
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $2,957 - $3,700	-41 Reduced 0.75%	5,439 $482,000
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $44,526 - $53,534	707 Added 14.81%	5,480 $415,000
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $16,162 - $20,659	-246 Reduced 4.9%	4,773 $347,000
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $59,860 - $70,453	776 Added 18.29%	5,019 $405,000
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $76,640 - $85,200	-862 Reduced 16.89%	4,243 $401,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $13,826 - $16,359	154 Added 3.11%	5,105 $473,000
Q1 2018 May 08, 2018	BUY	$92.01 - $123.21 $109,215 - $146,250	1,187 Added 31.54%	4,951 $469,000
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $44,780 - $49,105	-500 Reduced 11.73%	3,764 $364,000
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $297,840 - $380,434	4,264	4,264 $379,000

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bison Wealth, LLC with notifications on news.

Account